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Background: Hypertension is an overwhelming global challenge with high morbidity and mortality rates. The
prevalence of HTN is estimated to be 6% in Ethiopia and 30% in Addis Ababa. Poor adherence is associated with
bad outcome of the disease and wastage of healthcare resources. In Ethiopia, particularly in the study area little is
known about treatment adherence and associated factors. Therefore this study aimed to assess adherence to
antihypertensive therapy and associated factors among HTN patients on follow up at University of Gondar Referral
Hospital.
Method: Institution based cross sectional study was conducted. Systematic sampling technique was used to select
384 participants. A structured standard questionnaire was used after some modifications. Morisky Medication
Adherence Scale was used for labeling patients as adherent or non-adherent. Data were entered and analyzed
using SPSS version 16.
Results: More than half (64.6 %) of the study participants were found to be adherent to their treatment. Sex
(AOR = 0.48, 95%CI = 0.28, 0.82), knowledge about HTN and its treatment (AOR = 6.21, 95%CI = 3.22, 11.97), distance
from the hospital (AOR = 2.02, 95% CI =1.19-3.43) and co morbidity (AOR = 2.5, 95%CI = 1.01, 6.21) variables were
found significantly associated with treatment adherence.
Conclusion: Only 64.6% of the study subjects were found to be adherent to their treatment. Factors such as sex,
distance from the hospital, number of co morbidities, Knowledge about HTN and its treatment were associated
with adherence behavior of patients. Early diagnosis and management of co morbidities, adherence counseling and
patient education about the disease and its treatment are important to improve adherence status of patients.Background
Hypertension (HTN), or high blood pressure (systolic
blood pressure ≥140 mmHg and diastolic blood
pressure ≥90 mmHg) is an overwhelming global
challenge which ranks third as a cause of disability-
adjusted life-year [1]. Hypertension causes 7.1 mil-
lion premature deaths each year worldwide and
accounts for 13% of all deaths globally [2]. Analysis of
the global burden of hypertension revealed that over
26% of the world's adult population had hypertension in
2000 [3]. In developing countries, its morbidity and
mortality are increasing from time to time due to a* Correspondence: zelalem78@gmail.com
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reproduction in any medium, provided the orchange in life style and sedentary life. In Africa, 15% of
the population has hypertension [4]. Although there is
shortage of extensive data, 6% of the Ethiopian popula-
tion has been estimated to have HTN. Approximately
30% of adults in Addis Ababa have hypertension above
140/90 mmHg or reported use of anti-hypertensive
medication [5].
There are effective medical therapies for hypertension
management. However, only 37% of hypertensive patients
in a 2003-2004 survey were reported to have their blood
pressure controlled [6]. The problem of non-adherence to
medical treatment remains a challenge for the medical
professions and social scientists. As a result, substantial
numbers of patients do not get the maximum benefit of
medical treatment, resulting in poor health outcomes,
lower quality of life and increased health care costs. Inl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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adherence rates have remained nearly unchanged in the
last decades [1,7,8].
Poor adherence to anti-hypertensive therapy is one of
the biggest obstacles in therapeutic control of high blood
pressure [6]. It also compromises the efforts of the health
care system, policy makers and health care professionals
in improving the health of populations. Failure to adhere
causes medical and psychological complications of the
disease, reduces patients’ quality of life, wastes health
care resources and erodes public confidence in health
systems [9].
Poor adherence to anti-hypertensive therapy is usu-
ally associated with bad outcome of the disease and
wastage of limited health care resources. In Ethiopia,
particularly in the study area, little is known about
the adherence status and associated factors. Therefore,
the aim of this study was to assess the adherence sta-
tus and associated factors to antihypertensive therapy
among patients on follow up at University of Gondar
Hospital.Methods
Institution based cross-sectional survey was done at Uni-
versity of Gondar teaching Hospital from April to August
2011. The University of Gondar Teaching Hospital is
located in Gondar Town, Amhara National Regional State,
Ethiopia. The Town consisted of one central referral Hos-
pital and three health centers. Gondar University Hospital
is a teaching as well as regional referral Hospital under
ministry of education. The situation in Ethiopia is that
most of the Hospitals where Universities are located are
teaching referral Hospitals. The referral Hospital is meant
to serve 5 million people as per the four tier system of the
National Ministry of Health. Chronic illness care is one of
the services the Hospital provides to the population both
within and outside of Gondar Town. Provision of treat-
ments for hypertensive patients is one of the chronic ill-
nesses included in the chronic illness care. There were 968
patients on antihypertensive treatment at the chronic ill-
ness follow-up care. The study was conducted among
hypertensive patients of age 18 years and above receiving
antihypertensive treatment as outpatients at the University
of Gondar Referral Hospital. A single population propor-
tion formula, [n = (Z α/2)2 p (1-p)], was used to estimate
the sample size. The following assumptions were made:
since no previous data, proportion was taken as 50%
(p= 0.5), 95% confidence interval, margin of error 5%
(d= 0.05). Computing with the above formula gives a total
sample size of 384. Every other 2 patients were interviewed
when they come for follow up at the chronic care clinic
using systematic random sampling technique from the
registration list of patients.Controlled hypertension
Average BP reading less than 140/90 mmHg at the time of
data collection irrespective of measurements at other
times.
Knowledgeable
Respondents who scored above mean for the knowledge
questions.
Good patient-provider relationship
Participants who scored mean and above for questions
prepared on patient provider relationship in the treat-
ment and care of HTN patients otherwise not. A stand-
ard pretested questionnaire supplemented with patient
medical record review to counter check the clinical data
reports was used. Data were collected by trained nurses
working in the other wards of the hospital. Additional
two nurses were assigned to supervise the data collection
process. Morisky Medication Adherence Scale (MMAS),
a 4-item questionnaire with a high reliability and validity,
which has been particularly useful in chronic conditions
such as hypertension was used [10]. The scale is based
on patient`s self response [11]. The total score ranges
from 1 to 5. During analysis, a cut-off value of MMAS
mean score>=3 and <3 were used for labeling patients
as adherent or non-adherent respectively [12].
After participants are interviewed, two sitting BP mea-
surements were taken in the right arm with pre-tested
mercury/aneroid sphygmomanometers and stethoscopes
approximately 2 min apart and the average of the two
readings were used to determine the BP level. The cuff
size was 23 × 12.5 cm. For all readings Korotkoff phases I
and V were used to establish the levels of systolic and
diastolic blood pressure, respectively.
The data were entered and analyzed using SPSS ver-
sion 16 statistical package. Data cleaning was performed
to check for accuracy, consistency and there were no
missed values during entry. Frequencies, proportions and
summary statistics were used to describe the study popu-
lation in relation to relevant variables. Bivariate and
multivariate analyses were carried out to see the putative
associations of each independent variable with the
dependent variable. Odds ratio and 95% confidence
interval were also used to identify the presence and
strength of association.
Ethical approval from the institutional review board of
the University of Gondar was obtained. Permission to
conduct the study in follow-up unit was obtained from
the medical director’s office of the hospital. Each study
participant was adequately informed about the purpose,
method, anticipated benefit and risk of the study by the
data collectors. Verbal consent was obtained from study
participants and anonymity was maintained to ensure
confidentiality.
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Socio-demographic characteristics
A total of 384 study participants were interviewed mak-
ing the response rate 100%. The mean age of respon-
dents was 56.9 years with a standard deviation of 12.8.
Orthodox Christians and the Amhara ethnic group
accounted for 89.3% and 94% of the respondents respect-
ively. More than three fourth (76.6%) of the respondents
were urban by resident. Two hundred thirty three
(60.7%) reported to be married and 93(24.2%) were mer-
chants. For two hundred thirty three (60.7%), it takes half
an hour and above on single trip to reach to the hospital.
(Table 1)Table 1 Socio demographic characteristic of the study
participants (n = 384), GUH, Northwest Ethiopia, 2011
Variables Frequency Percent (%)
Sex Male 142 37.0
Female 242 63.0
Age 18-40 36 9.4
41-60 210 54.7
>= 60 138 35.9
Ethnicity Amhara 361 94.0
Tigrie 18 4.7
Others 5 1.3
Residence Rural 90 23.4
Urban 294 76.6




Religion Orthodox 343 89.3
Muslim 36 9.4
Others 5 1.3






Educational status Cannot read
and write
196 51
Grade 1-6 60 15.6




Monthly income <500 ETB 248 64.6
500-1000ETB 65 16.9
>= 1000ETB 71 18.5
Distance from the
hospital(single trip)
<0.5 h 151 39.3
> 0.5 h 233 60.7Clinical, medication and adherence characteristics
Near half (47.4%) of the respondents had no any of the co
morbidities like heart disease, diabetes mellitus, renal dis-
eases and others. More than half (53.4%) of the study sub-
jects had uncontrolled blood pressure. Regarding the
medication information, 154 (40.1%) of the subjects have
been taking only one drug while 45.3% and 14.6% of them
were on two and three and above (≥3) drugs, respectively.
Regarding the cost of medication, 59.6% of the respon-
dents were getting their medication for free. In addition,
data were also collected on the duration of treatment. Ac-
cordingly, 135 (35.2%) of them have been taking their
treatment for the last 2 to 4 years. The mean number of
pills taken per day was 2.5 with standard deviation of 1.4
(Table 2).Table 2 Medication and Blood pressure characteristic of
respondents, GUH, Northwest Ethiopia, 2011
Variables Frequency Percent
Number of co morbidity
None 182 47.4
1 170 44.3







Three and above 56 14.6
Dosage:
Once daily 179 46.6
BID 196 51.0
TID and above 9 2.3
Number of pills per day:
One pill 112 29.2
Two pills 99 25.8
Three pills 101 26.3
Four and above pills 72 18.8




Employer organization 15 3.9
Duration of treatment in yrs:
0.25-1 yrs 109 28.4
2-4 yrs 135 35.2
5-7 yrs 55 14.3
8-10 yrs 42 10.9
≥ 11 yrs 43 11.2
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herent to their treatment. Majority of the respondents
(76.8%) were knowledgeable about HTN and its
treatment.
Factors associated with antihypertensive treatment
adherence
The association of selected socio-demographic, clinical
and other characteristics on adherence status was investi-
gated using both the bivariate and multivariate logistic re-
gression technique. Accordingly, variables considered in
the bivariate analysis were: age, sex, residence, marital sta-
tus, religion, educational status, income, employment sta-
tus, number of co-morbidities, BP level, distance, dosage
frequency, duration of treatment, number of medications,
coverage of drug cost, knowledge about HTN and Patient
provider relationship. Explanatory variables with p value
up to 0.2 were included in the multiple logistic regressions.
Finally, sex, distance< 0.5 h from the hospital, having no
or one co-morbidity, having controlled BP, being
knowledgeable about HTN remained to be significantly
associated with adherence to treatment of HTN. (Table 3)
The multivariate logistic regression showed that as the
distance from the hospital decreased, the adherence to
treatment of HTN got improved (AOR=2.02, 95% CI=
1.19, 3.43). Those who have controlled HTN had a signifi-
cantly higher chance of being adherent to their treatment
(AOR=2.93, 95% CI (1.73, 4.96). The odds of adherence
to anti-HTN treatment among knowledgeable Clients was
6 times (AOR=6.21, 95%CI= 3.22, 11.97) higher than the
odds of adherence among HTN patients who were not
knowledgeable. The odds of adherence among study parti-
cipants with no or one co-morbidity were 2.5 and 2.68
times higher than the odds adherence among those who
had two co-morbidities (adjusted OR=2.50, 95%CI 1.01,
6.21) or more than two co-morbidities (adjusted OR=2.68,
95%CI 1.07, 6.71), respectively.
Discussion
Ensuring patients’ adherence to anti hypertension medi-
cations to prevent complications of hypertension
remains a major challenge to public health in many
developing countries. Poor adherence to treatment is the
single most important reason for uncontrolled hyperten-
sion, serious complications and wastage of health care
resources. Several factors, which may be patient or
health system related, continue to militate against com-
pliance behavior [9,13].
Only 64.6% of the study subjects were found to be ad-
herent to their treatment. It is higher than what has been
reported from Malaysia (44.2%) and Gambia 27% [10,14].
The adherence to antihypertensive treatment found in
the current study was also higher than that of 57% found
in the study done in Pakistan [15]. This difference ispossibly because more than half (59.6%) of the patients
in the current study receive free medical care and drugs
whereas in the other study patients had to pay for their
treatment. However, it is lower than the studies done in
Egypt (74.1%), another part of Pakistan (77%) and
Scotland (91%) [8,12,16]. This might be due to better ac-
cess and care to patients in these countries. It is also
supported by the findings of this study that, for 71.3% of
the non adherents, the hypertension treatment and care
service was not accessible.
In this study, significant association between sex and
adherence level was observed. Accordingly, men were
found to be less adherent when compared to women.
This finding is in line with a study done in India [12],
where men had almost threefold increase in risk of non-
adherence as compared to women. This can be explained
by the fact that; men are burdened by the outdoor activ-
ities which make them busy and make them forget their
medications. Alcohol consumption, a commonly practice
by males, could also be a barrier for their treatment
adherence.
Longer distance was a big barrier for adherence to
treatment recommendations especially when it was ac-
companied by poor infrastructure (e.g. lack of transpor-
tation) and poverty. Distance from the hospital was
another variable found to be significantly and independ-
ently associated with the adherence status of the respon-
dents. Those patients from distant areas were less likely
to be adherent as compared to study subjects who are
closer. This finding is supported by the study done in
India [12]. Patients who take long to come to the clinic
have certain characteristics that promote non-adherence,
which also delayed them from coming for review and
possibly collecting drugs from the hospital when they re-
fill the antihypertensive.
Co-morbidities can worsen the conditions of the pa-
tient and make them unable to adhere to their antihyper-
tensive medications. This study revealed that the
numbers of co morbidities among HTN patients had sig-
nificant associations on adherence behavior. Patients
with no and one co morbidities were more likely to ad-
here to their treatment than those with two and above
co morbidities. Patients with more number of co mor-
bidities could suffer from serious complications and
complex treatment regimens which were favorable con-
ditions not to adhere to their medications.
Right knowledge about HTN and its treatment creates a
clear understanding and avoids confusion about the treat-
ment and the disease condition. Knowledge about HTN
and its treatment was found to be positively associated
with adherence behavior. Patients with better awareness
were more likely to adhere to their treatment. A similar
study from Pakistan and Gaza demonstrated that patients
who were aware of their diseases and treatments had
Table 3 Effect of selected socio-demographic, clinical and other characteristics on adherence to antihypertensive
treatment, GUH, Northwest Ethiopia, 2011
Variables Adherence Status COR(95%CI) AOR(95%CI)
Adheren Non adherent
Sex Male 87 55 0.80(0.51, 1.22) 0.48(0.28, 0.82)**
Female 161 81 1 1
Residence Rural 51 39 1
Urban 197 97 1.55(0.96, 2.52)*
Marital Status Single 13 4 1
Married 157 76 0.64 (0.20, 2.02)*
Divorced 22 19 0.36 (0.10, 1.28)*
Widowed 56 37 0.47 (0.14, 1.52)*
Religion Orthodox 226 117 0.60(.31, 1.15)*
Others 22 19 1
Educational status Illiterate 119 77 1
Grade 1-6th 39 21 1.20(0.66, 2.20)*
Grade 7-12th 58 25 1.50(0.87, 2.60)*
Diploma and above 32 13 1.59(0.79, 3.23)*
Income level <= 500 ETB 152 96 1
501-100 ETB 39 26 0.95(0.54, 1.66)*
>= 1001 ETB 57 14 2.57(1.36, 4.87)*
Government worker 56 18 1.80(0.90, 3.64)*
Merchant 54 39 0.8(0.43, 1.49)*
Employment status Student 6 2 1.74(0.33, 9.19)*
House wife 57 30 1.10(0.58, 2.08)*
Farmer 25 18 0.81 (0.38, 1.72)*
Retired 50 29
No of co morbidities None 118 64 2.09(0.98, 4.46) 2.50(1.01, 6.21)**
One 115 55 2.37 (1.10, 5.09) 2.68(1.07, 6.71)**
Two and above 15 17 1 1
BP level Controlled 136 43 2.63(1.69, 4.08) 2.93(1.73, 4.96)**
Uncontrolled 112 93 1 1
Distance in hrs <0.5 hrs 112 39 2.05(1.31, 3.21) 2.02(1.19, 3.43)**
≥0.5 hrs 136 97 1 1
Dosage frequency Once daily 123 56 1.10 (0.27, 4.55)*
BID 119 77 0.77(0.19,3.18)*
TID and above 6 3 1
Knowledge towards Knowledgeable 224 71 8.55 (4.99, 14.65) 6.21(3.22, 11.97)**
HTN and its treatment Not Knowledgeable 24 65 1 1
Attitude Favourable 236 96 8.19 (4.12, 16.29) 3.23(1.31, 7.97)**
Not favourable 12 40 1 1
Pt-provider relationship Good 239 124 2.57( 1.05, 6.27)*
Poor 9 12 1
Note: - ** statistically significant * variables with p value of greater than 0.2 in crude analysis omitted from entering in to the model.
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However, in contrast to this finding, studies from some
developed world indicated no association between know-
ledge and adherence [18,19].In this study, blood pressure control level was asso-
ciated with adherence behavior. Those with controlled
blood pressure were observed to be adherent. This find-
ing is in line with the study done in Greece [19]. It might
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offer the patient good satisfactions and creates strong
motivation towards the treatment. However, bad out-
come (uncontrolled BP) could make the patient hopeless
and low satisfaction and hence urged them to stop their
treatment.
Conclusions
In conclusion, more than half of the study participants
were found to be adherent to their treatment. Factors
such as sex, distance from the hospital, number of co
morbidities, Knowledge about HTN and its treatment
were associated with adherence behavior of patients.
Early diagnosis and management of co morbidities, ad-
herence counseling and patient education about the dis-
ease and its treatment are important to improve
adherence status of patients.
This study have the following limitations: self-reporting
was used as the only method of measuring adherence.
This method has the disadvantages of recall bias and eli-
citing only socially acceptable responses and hence, may
overestimate the level of adherence. In addition, it did
not consider HTN patients who did not visit the hospital
during the time of the study. Hence, the extent of gener-
alisability is limited only to those similar patients who
are on chronic illness follow up care.
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